Navigation Links
Statins Show Promise Against Sickle Cell
Date:1/19/2010

The cholesterol drugs might reduce risk of infection, researchers find

TUESDAY, Jan. 19 (HealthDay News) -- The cholesterol drugs known as statins hold promise as a treatment for sickle cell disease, a common genetic disorder, new research has found.

The findings, published Jan. 19 in the Journal of Clinical Investigation, are based on experiments with mice, so it's not clear if humans with the disease will benefit from treatment with statins.

Researchers at St. Jude Children's Research Hospital in Memphis, Tenn., found that among mice with a type of sickle cell disease, those that were treated with statins lived much longer after being infected with pneumococcal bacteria than those who didn't get the treatment.

The cholesterol drugs appeared to stop cells from being killed by bacterial toxins and reduced the risk that germs would invade the blood system, according to the report.

Children with sickle cell disease face a serious threat from pneumococcal bacteria, and the researchers think preventive treatment with statins may reduce their risk of infection.

More information

The Nemours Foundation has more on sickle cell disease.



-- Randy Dotinga



SOURCE: Journal of Clinical Investigation, news release, Jan. 19, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. More Evidence That Statins Cut Stroke Risk
2. American Heart Association Late Breaking Clinical Trial Report: In Patients on Statins, Raising Good Cholesterol with Niacin, but not Reducing Bad Cholesterol with Ezetimibe, Decreases Plaque Build-Up
3. Statins May Stave Off Gallstones
4. Statins May Worsen Fatigue in Heart Failure Patients
5. Use of statins favors the wealthy, creating new social disparities in cholesterol
6. Study Suggests a Wider Use for Statins
7. Statins Before Vascular Surgery Cut Deaths, Complications
8. Giving Statins to Kids Provokes Debate
9. Blood vessel bends and branches put the brakes on statins
10. British Medical Journal Report Supports SCHS White Paper on Statins
11. Statins May Cause Muscle Damage in Some Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: